Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$32.56 - $38.57 $301,342 - $356,965
-9,255 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$27.83 - $37.73 $42,719 - $57,915
-1,535 Reduced 14.23%
9,255 $349,000
Q1 2020

May 12, 2020

SELL
$22.38 - $54.06 $13,204 - $31,895
-590 Reduced 5.18%
10,790 $312,000
Q4 2019

Feb 14, 2020

BUY
$51.85 - $73.36 $77,515 - $109,673
1,495 Added 15.12%
11,380 $590,000
Q3 2019

Nov 06, 2019

SELL
$40.05 - $57.47 $531,663 - $762,914
-13,275 Reduced 57.32%
9,885 $543,000
Q2 2019

Jul 26, 2019

SELL
$30.3 - $41.14 $377,235 - $512,193
-12,450 Reduced 34.96%
23,160 $941,000
Q1 2019

May 03, 2019

SELL
$29.37 - $40.49 $55,068 - $75,918
-1,875 Reduced 5.0%
35,610 $1.08 Million
Q4 2018

Feb 13, 2019

BUY
$30.16 - $43.0 $1.13 Million - $1.61 Million
37,485 New
37,485 $1.26 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $236M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Systematic Financial Management LP Portfolio

Follow Systematic Financial Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.